IF=10.8997,Journal for Immunotherapy of Cancer,复旦大学附属中山医院,慢病毒;质粒;siRNA.
ASCC3 promotes the immunosuppression and progression of non-small cell lung cancer by impairing the type I interferon response via CAND1-mediated ubiquitination inhibition of STAT3